Blueprint Medicines Corp reports results for the quarter ended in March - Earnings Summary

Blueprint Medicines

02/05/2024 19:55

* Blueprint Medicines Corp  BPMC.OQ  reported quarterly
adjusted
earnings of $1.40​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of $-2.15.  The mean expectation of
seventeen analysts for the quarter was for a loss of $1.66 per
share. Wall Street expected results to range from $-1.80
to $-1.46 per share.
    * Revenue rose 51.9% to $96.12 million from a year ago;
analysts
expected $80.43 million. 
    * Blueprint Medicines Corp's reported EPS for the quarter
was
$1.40​.
    * The company reported quarterly net income of $89.14
million.
    * Blueprint Medicines Corp shares had held steady so far
this
quarter and gained 2.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Blueprint
Medicines Corp is $113.00 
This summary was machine generated from LSEG data May 2 at 06:55
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.66          1.40           Beat
 Dec. 31 2023      -2.04          -1.82          Beat
 Sep. 30 2023      -2.37          -2.20          Beat
 Jun. 30 2023      -2.54          -2.19          Beat